Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Scheller Richard H, Director. Insider active across 6 companies, notably Oric Pharmaceuticals, Inc.. Cumulatively, 28 disclosures have been published. Split: 0 buy · 8 sells. Total volume traded: €4m. Activity tracked since 11 May 2021. The latest transaction was filed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Scheller Richard H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13,777 shares@ US$17.00100.0% of flowCommon StockSEC:0000899243-21-031954:0
25 of 28 declarations
About Scheller Richard H
SCHELLER RICHARD H is a Director at Alector, Inc., 23andMe Holding Co., BridgeBio Pharma, Inc., Oric Pharmaceuticals, Inc., DICE Therapeutics, Inc. and Maze Therapeutics, Inc. He has 28 filings, and across the 28 sampled filings between 2021-05-13 and 2026-06-17, sales amount to EUR 3975233, with no purchases reported, and the transaction nature shown as Attribution.